Impact of arterial occlusion location on early neurological deterioration in patients with minor stroke treated with intravenous thrombolysis. The MINORCAT-END study


Por: Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda-Gomez, C, Boned, S, Aragonès, JM, Silva, Y, Martínez, M, Doncel-Moriano, A, Ustrell, X, Camps-Renom, P, Mauri-Capdevila, G, Purroy, F, Rodríguez-Campello, A, Palomeras, E, Krupinski, J, Figueras-Aguirre, G, Catena, E, García-Alhama, J, Esteve-Belloch, P, Matos, N, Colom, C, Aguilo, O, Coll, A, Díaz, G, Tio, E, Ortega, O, Alfonso, S, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, de la Ossa, NP, Abilleira, S and Gomez-Choco, M

Publicada: 17 dic 2025 Ahead of Print: 17 dic 2025
Resumen:
Purpose To assess the proportion of early neurological deterioration (END) in patients with minor stroke, its impact on 3-month clinical outcomes, and the influence of large vessel occlusion (LVO) location on END development. Methods We analyzed patients from the CICAT Code Stroke Registry in Catalonia, Spain, between January 1, 2016, and December 31, 2021. Inclusion criteria were baseline NIHSS <= 5, treatment with intravenous thrombolysis (IVT) with or without endovascular treatment (EVT), and available acute vascular imaging. END was defined as an NIHSS increase of >= 4 points at 24-36 h post-treatment. Poor clinical outcome was defined as modified Rankin Scale (mRS) 3-6 at 3 months. Findings A total of 1,380 patients were included (median age 71 [IQR 59-79] years; 59% male; median NIHSS 4 [IQR 3-5]). LVO was present in 282 patients (20.4%). END occurred in 73 patients (5.3%): 12.1% with LVO vs. 3.6% without LVO (p < 0.001). LVO was the strongest predictor of END (OR 3.73; 95% CI 2.30-6.06; p < 0.001), regardless of occlusion level. Poor 3-month outcome was observed in 74% of patients with END, compared to 26.8% without END (p < 0.001). END independently predicted poor outcome (OR 6.79; 95% CI 3.23-14.31). Conclusions In minor stroke patients treated with IVT or IVT + EVT, LVO was the primary driver of END even for mediun-sized arteries. END emerged as the strongest predictor of poor 3-month functional outcome.

Filiaciones:
Font, MA:
 Consorci Hosp Vic, Neurol Dept, Vic, Spain

 UCC, Escola Doctorat, UVIC, Vic, Spain

García-Sánchez, SM:
 Complex Hosp Univ Moises Broggi, Neurol Dept, St Joan Despi, Spain

Mengual, JJ:
 Complex Hosp Univ Moises Broggi, Neurol Dept, St Joan Despi, Spain

Avellaneda-Gomez, C:
 Complex Hosp Univ Moises Broggi, Neurol Dept, St Joan Despi, Spain

Boned, S:
 Complex Hosp Univ Moises Broggi, Neurol Dept, St Joan Despi, Spain

Aragonès, JM:
 Consorci Hosp Vic, Neurol Dept, Vic, Spain

Silva, Y:
 Hosp Univ Dr Josep Trueta, Neurol Dept, Girona, Spain

Martínez, M:
 Hosp Univ Germans Trias i Pujol, Neurol Dept, Cerebrovasc Disorders Unit, Badalona, Spain

Doncel-Moriano, A:
 Hosp Clin Barcelona, Neurol Dept, Funct Unit Cerebrovasc Disorders, Barcelona, Spain

Ustrell, X:
 Hosp Univ Joan XXIII, Neurol Dept, Tarragona, Spain

Camps-Renom, P:
 Hosp Santa Creu & Sant Pau, Neurol Dept, Barcelona, Spain

Mauri-Capdevila, G:
 Hosp Univi Arnau de Vilanova, Neurol Dept, UdL, Grp Neurociencies Clin IRBLleida, Lleida, Spain

Purroy, F:
 Hosp Univi Arnau de Vilanova, Neurol Dept, UdL, Grp Neurociencies Clin IRBLleida, Lleida, Spain

Rodríguez-Campello, A:
 Hosp del Mar, Neurol Dept, Barcelona, Spain

Palomeras, E:
 Hosp Mataro, Neurol Dept, Mataro, Spain

Krupinski, J:
 F Ass Mutua Terrassa, Neurol Dept, Terrassa, Spain

 Manchester Met Univ, Dept Life Sci, Manchester, England

Figueras-Aguirre, G:
 Hosp Parc Tauli, Neurol Dept, Sabadell, Spain

Catena, E:
 Consorci Sanit Alt Penedes Garraf, Neurol Dept, Vilafranca Del Penedes, Spain

García-Alhama, J:
 Consorci Sanit Alt Penedes Garraf, Neurol Dept, Vilafranca Del Penedes, Spain

Esteve-Belloch, P:
 Hosp Verge de la Cinta, Neurol Dept, Tortosa, Spain

Matos, N:
 Hosp St Joan de Deu, Neurol Dept, Fundacio Althaia, Manresa, Spain

Colom, C:
 Hosp Igualada, Emergency Dept, Igualada, Spain

Aguilo, O:
 Univ Cent Catalunya, Univ Vic, Fac Med, Vic, Spain

 Hosp Olot & Comarcal de la Garrotxa, Emergency Dept, Girona, Spain

 Inst Recerca & Innovac Ciencies Vida Salut Catalu, Tissue Repair & Regenerat Lab TR2Lab, Vic, Spain

Coll, A:
 Hosp Olot & Comarcal de la Garrotxa, Emergency Dept, Girona, Spain

Díaz, G:
 Hosp Campdevanol, Emergency Dept, Campdevanol, Spain

Tio, E:
 Consorci Hosp Vic, Neurol Dept, Vic, Spain

 Univ Cent Catalunya, Univ Vic, Fac Med, Vic, Spain

Ortega, O:
 Consorci Hosp Vic, Neurol Dept, Vic, Spain

Alfonso, S:
 Consorci Hosp Vic, Neurol Dept, Vic, Spain

Jiménez-Fàbrega, X:
 Generalitat Catalunya, Invest & Dev Area, Serv Emergencies Med, Barcelona, Spain

Salvat-Plana, M:
 Pla Malaltia Vasc Cerebral, Dept Salut, Barcelona, Spain

Elosua, R:
 Univ Cent Catalunya, Univ Vic, Fac Med, Vic, Spain

 Hosp del Mar, Res Inst IMIM, Barcelona, Spain

 Inst Salud Carlos III, CIBER Enfermedades Cardiovasc, Barcelona, Spain

Abilleira, S:
 Pla Malaltia Vasc Cerebral, Dept Salut, Barcelona, Spain

Gomez-Choco, M:
 Complex Hosp Univ Moises Broggi, Neurol Dept, St Joan Despi, Spain

 Complex Hosp Univ Moises Broggi, Neurol Dept, Oriol Martorell 12, St Joan Despi 08970, Spain
ISSN: 15903478





Neurological Sciences
Editorial
Springer Verlag, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Alemania
Tipo de documento: Article
Volumen: 47 Número: 1
Páginas: 12-12
WOS Id: 001643622600002
ID de PubMed: 41405770

MÉTRICAS